 price
juuuuust bit outsid appli
take get thing right work us
unfortun matter bit
normal tomorrow particularli face multipl expans
driven belief growth would acceler hsd thu
new product momentum appear intact key upsid
driver like vanadi cannabi continu trend favor albeit
smaller piec busi macro pmi driven area
experienc weak like persist indefinit
period time name eu industri china appli fortun
strong cost manag kept dream aliv
model struggl get fulli unless core acceler north
next year struggl assumpt base
macro back-drop today thu like move higher
share still extend rel histori valuat remain
sidelin mention capit alloc subdu
mid-to-l leverag continu move lower pend
wat print tomorrow wouldnt shock see whole
group bit pressur particularli further view
pleas see analyst certif import disclosur page report evercor isi affili seek busi
compani cover research report investor awar firm may conflict interest could affect object
report investor consid report singl factor make invest decis
lower revenu bn bn lower organ
organ revenu growth fx
omx alreadi done ytd bp remaind om
maintain ep
lower convers vs prior
due custom shift larger order later part lead build inventori meet
demand trend
receiv later sale instrument mm evolv busi model
informatics/subscript cannabi day pay vs customari day pay
organ revenu growth
adj ep forecast adjust ep
call particularli strong
signific hw china
cisbio hsd
industrial/environment msd
food dd led cannabi
china food show strength grain dairi
safeti market show growth
china weak analyt instrument relat tariff
reproduct hsd
immunodx mid-teen
appli msd
cannabi ramp
vanadi track placement placement
cisbio reagent busi mm integr go well
work cap pressur greater order later carri inventori meet need
convers year
multi-million order cross-funct suit product
inclus cisbio creat whole portfolio fluoresc
look improv workflow genom cannabi
valuat methodolog base mix discount cash flow analysi rel valuat multipl
risk valuat includ regulatori risk overal market risk well unforeseen event relat individu cover
compani broader sector includ new competit product technolog
laboratori corp america
articl articl
time dissemin juli
analyst luke sergott jon bristow ross muken primarili respons prepar research report attest follow
view opinion render research report reflect person view subject compani issuer
part research analyst compens directli relat specif recommend view research report
